The journal retracts the publication “Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of an image presented in this publication [1].
In accordance with the journal’s standard editorial procedures, the Editorial Office and the Editorial Board conducted an investigation, which identified indications of inappropriate editing and partial duplication of panels within Figure 1, as well as between panels in Figure 1 and panels presented in a previous publication [2], produced by a different research group and presenting different experimental conditions. The authors did not provide a comment on this concern. Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy.
This retraction was approved by the Editor-in-Chief of the journal Molecules.
The authors have been informed of this retraction but did not provide a comment on this decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Hong M., Cheng H., Song L., Wang W., Wang Q., Xu D., Xing W. RETRACTED: Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma. Molecules. 2018;23:384. doi: 10.3390/molecules23020384. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Berges R., Baeza-Kallee N., Tabouret E., Chinot O., Petit M., Kruczynski A., Figarella-Branger D., Honore S., Braguer D. End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo. Oncotarget. 2014;5:12769–12787. doi: 10.18632/oncotarget.2646. [DOI] [PMC free article] [PubMed] [Google Scholar]